SCHEMBL1650480

SCHEMBL1650480

O=C1C=CC(=O)c2[nH]ccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 1.00
CDC25B P30305 4/20 0.43
MAP2K1 Q02750 2/20 0.43
PIN1 Q13526 2/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
AKT1 P31749 1/20 0.43
SNCA P37840 1/20 0.43
EHMT2 Q96KQ7 1/20 0.43
NSD1 Q96L73 1/20 0.43
EHMT1 Q9H9B1 1/20 0.43
MAPT P10636 4/20 0.33
CRBN Q96SW2 1/20 0.33
KMT2A Q03164 3/20 0.32
S100A4 P26447 2/20 0.32
TP53 P04637 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
THRB P10828 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6407655 0.70 IDO1 (0.54) IDO1CDC25BMAP2K1PIN1MAOA
SCHEMBL24404193 0.69 IDO1 (0.52) IDO1CDC25BMAP2K1MAOAMAPT
SCHEMBL15762826 0.69 IDO1 (0.52) IDO1CDC25BMAP2K1MAOAMAPT
SCHEMBL31357464 0.69 IDO1 (0.52) IDO1CDC25BMAP2K1PIN1MAOA
SCHEMBL4052052 0.65 IDO1 (0.48) IDO1MAPTCRBNKMT2AKDM4E
SCHEMBL6364569 0.62 DNMT1 (0.49) IDO1MAP2K1MAPTKMT2AS100A4
SCHEMBL21305078 0.62 MAP2K1 (0.61) IDO1MAP2K1MAOAMAOBMAPT
SCHEMBL311991 0.62 ALOX15 (0.48) IDO1MAP2K1MAPTCRBNALDH1A1
Naphthoquinone SCHEMBL28536412 0.62 IDO1 (0.70) IDO1CDC25BMAP2K1PIN1MAOA
SCHEMBL3958516 0.62 IDO1 (0.44) IDO1CDC25BMAP2K1PIN1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070000073-A1 Agent and method for colouring keratin fibres PROCTER & GAMBLE COMPANY, THE 2007-01-04 US claimed
WO-2006094217-A2 AGENT AND METHOD FOR COLOURING KERATIN FIBRES THE PROCTER & GAMBLE COMPANY (US) 2006-09-08 WO claimed
US-7070625-B2 Agent and method for coloring keratin fibers containing 2-benzothiazolinone-hydrazone and quinone derivatives WELLA AG (DE) 2006-07-04 US claimed
US-20040060124-A1 Agent and method for coloring keratin fibers containing 2-benzothiazolinone-hydrazone and quinone derivatives HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-04-01 US claimed
EP-0957891-B1 REDUCTION OF HAIR GROWTH GILLETTE CO (US) 2003-03-19 EP claimed
US-6037326-A APPLYING TO THE SKIN AN INHIBITOR OF A DNA TOPOISOMERASE GILLETTE COMPANY, THE 2000-03-14 US claimed
EP-0957891-A1 REDUCTION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1999-11-24 EP claimed
WO-1998029086-A1 REDUCTION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1998-07-09 WO claimed
EP-0324109-B1 6-SUBSTITUTED MITOMYCIN ANALOGS UNIVERSITY PATENTS, INC. (US) 1993-09-29 EP claimed
US-4791130-A ANTITUMOR AGENTS. KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1988-12-13 US claimed
US-11530181-B2 IL-6 inhibitors and methods of treatment UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2022-12-20 US disclosed
CN-110734423-B Indoloquinone indoleamine-2,3-dioxygenase inhibitor and medicinal application thereof 复旦大学 2022-07-08 CN disclosed
US-20210206718-A1 IL-6 INHIBITORS AND METHODS OF TREATMENT UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2021-07-08 US disclosed
WO-2019165158-A1 IL-6 INHIBITORS AND METHODS OF TREATMENT UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2019-08-29 WO disclosed
US-7927613-B2 Pharmaceutical co-crystal compositions UNIVERSITY OF SOUTH FLORIDA (US) 2011-04-19 US disclosed
EP-0957891-B1 REDUCTION OF HAIR GROWTH GILLETTE CO (US) 2003-03-19 EP disclosed
US-6037326-A APPLYING TO THE SKIN AN INHIBITOR OF A DNA TOPOISOMERASE GILLETTE COMPANY, THE 2000-03-14 US disclosed
EP-0957891-A1 REDUCTION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1999-11-24 EP disclosed
WO-1998029086-A1 REDUCTION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1998-07-09 WO disclosed
EP-0242160-A2 Mitomycin derivatives KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1987-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530181-B2 IL-6 inhibitors and methods of treatment IL6, IL6ST, IL2 IDO1 297/4885CDC25B 2296/4885MAP2K1 2227/4885
US-20040060124-A1 Agent and method for coloring keratin fibers containing 2-benzothiazolinone-hydrazone and quinone derivatives KRT18, NDUFA1, NDUFA2 IDO1 1036/4885CDC25B 1366/4885MAP2K1 205/4885
US-20210206718-A1 IL-6 INHIBITORS AND METHODS OF TREATMENT IL6, IL6ST, IL2 IDO1 297/4885CDC25B 2296/4885MAP2K1 2227/4885
US-20070000073-A1 Agent and method for colouring keratin fibres KRT18, CDC73, OAT IDO1 3218/4885CDC25B 1550/4885MAP2K1 418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.